William Plovanic
Stock Analyst at Canaccord Genuity
(3.72)
# 794
Out of 5,133 analysts
168
Total ratings
50.67%
Success rate
7.48%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $20.90 | +67.46% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $142.71 | +3.71% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $5.93 | +102.53% | 5 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $87 | $83.84 | +3.77% | 30 | Dec 17, 2025 | |
| CBLL CeriBell | Maintains: Buy | $29 → $30 | $22.79 | +31.64% | 5 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 → $131 | $94.14 | +39.15% | 13 | Dec 17, 2025 | |
| PODD Insulet | Maintains: Buy | $428 → $432 | $278.17 | +55.30% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $32.07 | +24.73% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $42.90 | +18.88% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $6.11 | +80.03% | 9 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $193 → $212 | $155.44 | +36.39% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $99 | $70.25 | +40.93% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $64 | $36.40 | +75.82% | 12 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $10.07 | +78.75% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.80 | +288.89% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $90.16 | -0.18% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $88.34 | +14.33% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.70 | +94.81% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $300.97 | -5.64% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $16.45 | +51.98% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.95 | +515.38% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $81.08 | -13.67% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $21.13 | +127.17% | 5 | Aug 3, 2023 |
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $20.90
Upside: +67.46%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $142.71
Upside: +3.71%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $5.93
Upside: +102.53%
Edwards Lifesciences
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $83.84
Upside: +3.77%
CeriBell
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $22.79
Upside: +31.64%
Boston Scientific
Dec 17, 2025
Maintains: Buy
Price Target: $132 → $131
Current: $94.14
Upside: +39.15%
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $278.17
Upside: +55.30%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $32.07
Upside: +24.73%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $42.90
Upside: +18.88%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $6.11
Upside: +80.03%
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $155.44
Upside: +36.39%
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $70.25
Upside: +40.93%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $36.40
Upside: +75.82%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $10.07
Upside: +78.75%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.80
Upside: +288.89%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $90.16
Upside: -0.18%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $88.34
Upside: +14.33%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.70
Upside: +94.81%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $300.97
Upside: -5.64%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $16.45
Upside: +51.98%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.95
Upside: +515.38%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $81.08
Upside: -13.67%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $21.13
Upside: +127.17%